High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: A case series

Nephron - Clinical Practice

Volumn 98, Issue 3, 2004, Pages

  Wu, Jean ^a,b   Jaar, Bernard G ^a   Briggs, William A ^a   Choi, Michael J ^a   Kraus, Edward S ^a   Racusen, Lorraine C ^a   Atta, Mohamed G ^a   Samaniego, Milagros D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Glomerular disease; Mycophenolate mofetil; Renal transplantation

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANCICLOVIR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DISEASE MARKER; FEMALE; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; GLOMERULOPATHY; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NAUSEA; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; REMISSION;

ADULT; AGED; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; REMISSION INDUCTION;

EID: 8344276627     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080674     Document Type: Article

References (19)

1. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002;347:103-109.
2. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR). Transplantation 1999;68:635-641.
3. Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, Briggs WA: Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002;61:1098-1114.
4. Mok CC, Lai KN: Mycophenolate mofetil in lupus glomerulonephritis. Am J Kidney Dis 2002;40:447-457.
5. Waiser J, Budde K, Braasch E, Neumayer HH: Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil. Am J Kidney Dis 1999;34:e9.
6. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-1971.
7. Harzallah K, Badid C, Fouque D, Lefrancois N, Touraine JL, Laville M: Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation. Clin Nephrol 2003;59:212-216.
8. Denton MD, Galvanek EG, Singh A, Sayegh MH: Membranous lupus nephritis in a renal allograft: Response to mycophenolate mofetil therapy. Am J Transplant 2001;1:288-292.
9. Adams PL, Iskandar SS, Rohr MS: Biopsy-proven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft. Am J Kidney Dis 1999;33:552-554.
10. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C: Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997;63:39-47.
11. Neylan JF: Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1997;64:1277-1282.
12. Furness PN, Roberts IS, Briggs JD: Recurrent glomerular disease in transplants. Transplant Proc 2002;34:2422.
13. Hariharan S, Peddi VR, Savin VJ, Johnson CP, First MR, Roza AM, Adams MB: Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 1998;31:928-931.
14. Briggs JD, Jones E: Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999;14:564-565.
15. Montagnino G, Tarantino A, Cesana B, Rossini G, Da Milano I, Arodi A, Elli A, Ponticelli C: Prognostic factors of long-term allograft survival in 632 CyA-treated recipients of a primary renal transplant. Transpl Int 1997;10:268-275.
16. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-883.
17. Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, D'Agati VD, Appel GB: Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001;56:271-278.
18. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D: Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004;350:971-980.
19. Cox VC, Ensom MH: Mycophenolate mofetil for solid organ transplantation: Does the evidence support the need for clinical pharmacokinetic monitoring? Ther Drug Monit 2003;25:137-157.